FIGURE

Fig. 7

ID

ZDB-FIG-120323-8

Publication

Chen et al., 2011 - Establishment of a transgenic zebrafish line for superficial skin ablation and functional validation of apoptosis modulators in vivo

Other Figures

All Figure Page

Back to All Figure Page

Fig. 7

Skin ablation in Met-treated killer line specifically targeted the EVL and showed no bystander effect on the neighboring cells.

Whole-mount immunostaining on killer line embryos aged at 48 hpf showing that the number of epidermal stem basal cells (A and B, stained with p63 antibody), NaRC (C and D, stained with Na,K-ATPase antibody), HRC (E and F, stained with H-ATPase antibody) and MC (G and H, stained with anterior gradient 2 antibody) did not significantly change between untreated (-Met) and treated (+Met) groups. (I–L) Statistical comparisons, using Student′s t-test, of the relative cell numbers of p63⁺ cells, NaRC, HRC and MC between untreated (-Met) and Met-treated (+Met) groups. The cell number is presented as the mean±S.D. NaRC, Na-K-ATPase rich cell; HRC, H-ATPase rich cells; MC, mucous cells; Met, metrodinazole.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ PLoS One